0 Commentarii
0 Distribuiri
458 Views
0 previzualizare
Căutare
Descoperă oameni noi, creează noi conexiuni și faceti-va noi prieteni
-
Vă rugăm să vă autentificați pentru a vă dori, partaja și comenta!
-
Gene Therapy Cell Culture Media Market Growth: Innovations and Key DriversThe Gene Therapy Cell Culture Media Market growth is fueled by significant advancements in cell therapy technologies and the increasing demand for personalized treatments. Biopharmaceutical companies are focusing on creating culture media with enhanced nutrient compositions to improve cell proliferation and functionality. Innovations in chemically defined media, serum-free...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare
-
Crigler-Najjar Syndrome Treatment: Orphan Drug Research at 5.60% CAGR to 2032"Key Drivers Impacting Executive Summary Crigler-Najjar Syndrome Treatment Market Size and Share The global Crigler-Najjar Syndrome treatment market size was valued at USD 150.50 million in 2024 and is expected to reach USD 232.72 million by 2032, at a CAGR of 5.60% during the forecast period The Crigler-Najjar Syndrome Treatment Market report contains...0 Commentarii 0 Distribuiri 454 Views 0 previzualizare
-
Gene Therapy Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"Executive Summary Gene Therapy Market: Growth Trends and Share Breakdown The global gene therapy market size was valued at USD 10.26 billion in 2024 and is expected to reach USD 39.38 billion by 2032, at a CAGR of 18.30% during the forecast periodThe market growth is largely fueled by the growing demand for curative therapies and rising investments in gene therapy research. Technological...0 Commentarii 0 Distribuiri 316 Views 0 previzualizare
-
RNA Therapeutics Market Accelerates with Breakthroughs in Precision MedicineGlobal Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA Therapeutics...0 Commentarii 0 Distribuiri 1K Views 0 previzualizare